State-Level Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in the United States, 2011 to 2023
Saved in:
| Main Authors: | Ryan Chang, BA, Tarang Parekh, PhD, MBBS, Kobina K. Hagan, MBChB, MPH, Zulqarnain Javed, MD, PhD, MBBS, MPH, John W. Ostrominski, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | JACC: Advances |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772963X25001711 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Social Determinants of Health and Mortality in Cardiovascular-Kidney-Metabolic Syndrome
by: Ryan Chang, BA, et al.
Published: (2025-09-01) -
Effect of Frailty on Cardiovascular Clinical Trials
by: Haowen Jiang, MBBS, et al.
Published: (2025-07-01) -
Trends and differences in the rates of autopsy in the United States, 2003 to 2020: A nationwide analysis
by: Dean M. Nelson, BBiomed, MD, et al.
Published: (2025-08-01) -
Systematic Review of Kidney Injury Biomarkers for the Evaluation of CKD of Uncertain Etiology
by: Sophie E. Claudel, et al.
Published: (2024-06-01) -
Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue
by: G. G. Arabidze, et al.
Published: (2024-06-01)